Company
Clinical Laserthermia Systems AB
Headquarters: Lund, Sweden
Employees: 7
CEO: Mr. Lars-Erik T. Eriksson
Market Cap
kr186.9 Million
SEK as of Jan. 1, 2024
US$18.6 Million
Clinical Laserthermia Systems AB Categories
Sweden Healthcare Medical DevicesSweden Healthcare Sweden Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Clinical Laserthermia Systems AB (publ) develops and sells laser-based treatment systems under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system with integrated Thermoguide TMàÂWorkstation, an advanced medical technology product consisting of a laser treatment unit and associated disposable products. It also is developing imILT, an immunostimulatory interstitial laser treatment for breast, skin, lung, prostate, kidney, liver, and pancreas tumors, as well as other solid cancer tumors. The company has a clinical trial collaboration with Toronto General Hospital regarding MRI-guided laser ablation treatment of prostate cancer. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Clinical Laserthermia Systems AB has the following listings and related stock indices.
Stock: OMX: CLS.B wb_incandescent
Stock: FSX: LS6 wb_incandescent